Article info
PDFInflammatory bowel disease
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
- Correspondence to Professor Jacques Cosnes, Gastroenterology and Nutrition Department, Saint-Antoine hospital, AP-HP, 184 rue du faubourg Saint Antoine, Paris 75012, France; jacques.cosnes{at}sat.ap-hop-paris.fr
Citation
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
Publication history
- Revised May 12, 2010
- Accepted May 15, 2010
- First published June 29, 2010.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.